Register for IndieBio SF’s VC-Founder Meetings + Demo Day  – Week of January 26, 2026

Learn more about investing in Microgenesis

Our team will get back to you soon to follow up on your inquiry.
Opt-In Checkbox
We don’t spam. Our Privacy Policy and Cookie Policy apply. The site is protected by reCAPTCHA.
Microgenesis
A new fertility test and treatment for women everywhere
Founded
2019
Employees*
2-10
Funding to Date*
$200K
* Data source: Crunchbase
Gabriela Guiterrez, Ph.D., CEO
At Microgenesis, we detangle age from inflammation.
Infertility affects 15% of all couples.

Microgenesis has worked with some of the hardest infertility cases there are – women who have undergone and failed multiple rounds of IVF. With a cohort of 287 would-be mothers, over 75% of their patients became pregnant using their proprietary test and nutraceutical regimen. Microgenesis uses microRNA signatures, on swabs from the fertility biome, to diagnose 64 phenotypes. They treat patients with 53 combinations of probiotics, nutraceuticals and diet-change. With personalized nutraceuticals and probiotics it resets fertility in 90 days.